Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
ipo
6
×
life sciences
national blog main
boston top stories
cancer
clinical trials
fda
national top stories
san francisco blog main
san francisco top stories
sanofi
cancer drugs
deals
investing
new york blog main
new york top stories
startups
venture capital
biogen
boulder/denver blog main
boulder/denver top stories
covid-19
deerfield management
detroit blog main
detroit top stories
drug discovery
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
melinta therapeutics
national
novartis
oric pharmaceuticals
raleigh-durham blog main
raleigh-durham top stories
revolution medicines
What
ipo
6
×
medicines
bio
cancer
covid
developing
new
proteins
research
revolution
roundup
way
acquisitions
activity
announced
approvals
biogen
biotech
cancer’s
ceo
clamped
collabs
company
company’s
course
daniel
deal
debut
delays
despite
development
discover
disease
drug
economic
experimental
family
fast
fda
frontiers
Language
unset
6
×
Current search:
ipo
×
ipo
×
unset
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline